Geode Capital Management’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264K | Sell |
249,351
-4,572
| -2% | -$4.85K | ﹤0.01% | 3779 |
|
|
2025
Q1 | $345K | Buy |
253,923
+26,127
| +11% | +$35.5K | ﹤0.01% | 3673 |
|
|
2024
Q4 | $314K | Buy |
227,796
+7,634
| +3% | +$10.5K | ﹤0.01% | 3747 |
|
|
2024
Q3 | $236K | Buy |
220,162
+39,239
| +22% | +$42K | ﹤0.01% | 3854 |
|
|
2024
Q2 | $389K | Buy |
180,923
+1,553
| +0.9% | +$3.34K | ﹤0.01% | 3664 |
|
|
2024
Q1 | $583K | Buy |
179,370
+747
| +0.4% | +$2.43K | ﹤0.01% | 3551 |
|
|
2023
Q4 | $3.66M | Buy |
178,623
+88,932
| +99% | +$1.82M | ﹤0.01% | 2857 |
|
|
2023
Q3 | $1.44M | Buy |
89,691
+36,729
| +69% | +$591K | ﹤0.01% | 3186 |
|
|
2023
Q2 | $450K | Sell |
52,962
-91,985
| -63% | -$782K | ﹤0.01% | 3684 |
|
|
2023
Q1 | $1.43M | Buy |
144,947
+21,862
| +18% | +$216K | ﹤0.01% | 3174 |
|
|
2022
Q4 | $1.17M | Buy |
123,085
+39,794
| +48% | +$379K | ﹤0.01% | 3279 |
|
|
2022
Q3 | $1.45M | Buy |
83,291
+6,824
| +9% | +$119K | ﹤0.01% | 3210 |
|
|
2022
Q2 | $592K | Buy |
+76,467
| New | +$592K | ﹤0.01% | 3672 |
|